跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,600 条关于
“Portola Pharmaceuticals”
全部
9,600
临床试验
1,201
药物
1,727
机构
2,060
资讯
4,612
23天前
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
9个月前
AstraZeneca Voluntarily Withdraws Andexxa from US Market Following Fatal Thromboembolic Events
去年
FDA Places Partial Clinical Hold on Kezar's Autoimmune Hepatitis Trial of Zetomipzomib
去年
FDA Halts Kezar's Lupus Nephritis Trial of Zetomipzomib Following Patient Deaths
11个月前
Kezar Life Sciences Faces FDA Setback for Autoimmune Hepatitis Drug, Explores Strategic Alternatives
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets
去年
ARIAD Pharmaceuticals Accelerates Ponatinib to Market
去年
OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger
第 1 页,共 462 页
上一页
下一页